{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:49:43Z","timestamp":1791607783095,"version":"4.3.4"},"reference-count":29,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,10,10]]},"DOI":"10.1248\/bpb.b26-00345","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:12:43Z","timestamp":1791583963000},"page":"1659-1666","source":"Crossref","is-referenced-by-count":0,"title":["Effects of ONO-6950, a Novel Dual Cysteinyl Leukotriene 1 and 2 Receptor Antagonist, in a Rat Model of Pulmonary Arterial Hypertension"],"prefix":"10.1248","volume":"49","author":[{"given":"Akihiro","family":"Kamiya","sequence":"first","affiliation":[{"name":"Research Center of Neurology, Ono Pharmaceutical Co., Ltd., 3\u20131\u20131 Sakurai, Shimamoto, Mishima-gun, Osaka 618\u20138585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masabumi","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060\u20130812, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sommer N, Ghofrani HA, Pak O, Bonnet S, Provencher S, Sitbon O, Rosenkranz S, Hoeper MM, Kiely DG. Current and future treatments of pulmonary arterial hypertension. <i>Br. J. Pharmacol.<\/i>, <b>178<\/b>, 6\u201330 (2021).","DOI":"10.1111\/bph.15016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Humbert M, Guignabert C, Bonnet S, Dorfm\u00fcller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. <i>Eur. Respir. J.<\/i>, <b>53<\/b>, 1801887 (2019).","DOI":"10.1183\/13993003.01887-2018"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zolty R. Pulmonary arterial hypertension specific therapy: The old and the new. <i>Pharmacol. Ther.<\/i>, <b>214<\/b>, 107576 (2020).","DOI":"10.1016\/j.pharmthera.2020.107576"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Perros F, Montani D, Dorfm\u00fcller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herv\u00e9 P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. <i>Am. J. Respir. Crit. Care Med.<\/i>, <b>178<\/b>, 81\u201388 (2008).","DOI":"10.1164\/rccm.200707-1037OC"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Gali\u00e9 N, G\u00f3mez-S\u00e1nchez MA, Grimminger F, Gr\u00fcnig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. <i>Circulation<\/i>, <b>127<\/b>, 1128\u20131138 (2013).","DOI":"10.1161\/CIRCULATIONAHA.112.000765"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hoeper MM, Badesch DB, Ghofrani HA, <i>et al<\/i>. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. <i>N. Engl. J. Med.<\/i>, <b>388<\/b>, 1478\u20131490 (2023).","DOI":"10.1056\/NEJMoa2213558"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Smedeg\u00e5rd G, Hedqvist P, Dahlen SE, Revenas B, Hammarstrom S, Samuelsson B. Leukotriene C<sub>4<\/sub> affects pulmonary and cardiovascular dynamics in monkey. <i>Nature<\/i>, <b>295<\/b>, 327\u2013329 (1982).","DOI":"10.1038\/295327a0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Weiss JW, Drazen JM, Coles N, McFadden ER Jr, Weller PF, Corey EJ, Lewis RA, Austen KF. Bronchoconstrictor effects of leukotriene C in humans. <i>Science<\/i>, <b>216<\/b>, 196\u2013198 (1982).","DOI":"10.1126\/science.7063880"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hanna CJ, Bach MK, Pare PD, Schellenberg RR. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle <i>in vitro<\/i>. <i>Nature<\/i>, <b>290<\/b>, 343\u2013344 (1981).","DOI":"10.1038\/290343a0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sekioka T, Kadode M, Yonetomi Y, Kamiya A, Fujita M, Nabe T, Kawabata K. CysLT<sub>2<\/sub> receptor activation is involved in LTC<sub>4<\/sub>-induced lung air-trapping in guinea pigs. <i>Eur. J. Pharmacol.<\/i>, <b>794<\/b>, 147\u2013153 (2017).","DOI":"10.1016\/j.ejphar.2016.11.036"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Stenmark KR, James SL, Voelkel NF, Toews WH, Reeves JT, Murphy RC. Leukotriene C<sub>4<\/sub> and D<sub>4<\/sub> in neonates with hypoxemia and pulmonary hypertension. <i>N. Engl. J. Med.<\/i>, <b>309<\/b>, 77\u201380 (1983).","DOI":"10.1056\/NEJM198307143090204"},{"key":"12","unstructured":"12) Lynch KR, O\u2019Neill GP, Liu Q, <i>et al<\/i>. Characterization of the human cysteinyl leukotriene CysLT<sub>1<\/sub> receptor. <i>Nature<\/i>, <b>399<\/b>, 789\u2013793 (1999)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Heise CE, O\u2019Dowd BF, Figueroa DJ, <i>et al<\/i>. Characterization of the human cysteinyl leukotriene 2 receptor. <i>J. Biol. Chem.<\/i>, <b>275<\/b>, 30531\u201330536 (2000).","DOI":"10.1074\/jbc.M003490200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mita H, Hasegawa M, Saito H, Akiyama K. Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils. <i>Clin. Exp. Allergy<\/i>, <b>31<\/b>, 1714\u20131723 (2001).","DOI":"10.1046\/j.1365-2222.2001.01184.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gauvreau GM, Plitt JR, Baatjes A, MacGlashan DW. Expression of functional cysteinyl leukotriene receptors by human basophils. <i>J. Allergy Clin. Immunol.<\/i>, <b>116<\/b>, 80\u201387 (2005).","DOI":"10.1016\/j.jaci.2005.03.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sj\u00f6str\u00f6m M, Johansson AS, Schr\u00f6der O, Qiu H, Palmblad J, Haeggstr\u00f6m JZ. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>23<\/b>, e37\u2013e41 (2003).","DOI":"10.1161\/01.ATV.0000082689.46538.DF"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Duah E, Adapala RK, Al-Azzam N, Kondeti V, Gombedza F, Thodeti CK, Paruchuri S. Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT<sub>2<\/sub> and CysLT<sub>1<\/sub> receptors. <i>Sci. Rep.<\/i>, <b>3<\/b>, 3274 (2013).","DOI":"10.1038\/srep03274"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Walch L, Norel X, B\u00e4ck M, Gascard JP, Dahl\u00e9n SE, Brink C. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle. <i>Br. J. Pharmacol.<\/i>, <b>137<\/b>, 1339\u20131345 (2002).","DOI":"10.1038\/sj.bjp.0704991"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Labat C, Ortiz JL, Norel X, Gorenne I, Verley J, Abram TS, Cuthbert NJ, Tudhope SR, Norman P, Gardiner P. A second cysteinyl leukotriene receptor in human lung. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>263<\/b>, 800\u2013805 (1992).","DOI":"10.1016\/S0022-3565(25)10418-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yonetomi Y, Sekioka T, Kadode M, Kitamine T, Kamiya A, Inoue A, Nakao T, Nomura H, Murata M, Nakao S, Nambu F, Fujita M, Nakade S, Kawabata K. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma. <i>Eur. J. Pharmacol.<\/i>, <b>765<\/b>, 242\u2013248 (2015).","DOI":"10.1016\/j.ejphar.2015.08.041"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Gonca E. The effects of zileuton and montelukast in reperfusion-induced arrhythmias in anesthetized rats. <i>Curr. Ther. Res. Clin. Exp.<\/i>, <b>75<\/b>, 27\u201332 (2013).","DOI":"10.1016\/j.curtheres.2013.06.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hagar HH, Alhazmi SM, Arafah M, Bayoumy NM. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism <i>via<\/i> modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats. <i>Naunyn Schmiedebergs Arch. Pharmacol.<\/i>, <b>397<\/b>, 3425\u20133435 (2024).","DOI":"10.1007\/s00210-023-02812-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Miyata M, Sakuma F, Ito M, Ohira H, Sato Y, Kasukawa R. Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration. <i>Int. Arch. Allergy Immunol<\/i>., <b>121<\/b>, 246\u2013252 (2000).","DOI":"10.1159\/000024324"},{"key":"24","unstructured":"24) Ono S, Noda M, Tanita T, Hoshikawa Y, Tabata T, Ueda S, Nishimura T, Ashino Y, Koike K, Fujimura S. Role of peptide leukotrienes in monocrotaline-induced lung disease. <i>Nihon Kyobu Shikkan Gakkai Zasshi<\/i>, <b>33<\/b>, 1415\u20131420 (1995)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) van Suylen RJ, Smits JF, Daemen MJ. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. <i>Am. J. Respir. Crit. Care Med.<\/i>, <b>157<\/b>, 1423\u20131428 (1998).","DOI":"10.1164\/ajrccm.157.5.9709050"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kaetsu Y, Yamamoto Y, Sugihara S, Matsuura T, Igawa G, Matsubara K, Igawa O, Shigemasa C, Hisatome I. Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells <i>in vivo<\/i> and <i>in vitro<\/i>. <i>Cardiovasc. Res.<\/i>, <b>76<\/b>, 160\u2013166 (2007).","DOI":"10.1016\/j.cardiores.2007.05.018"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Duah E, Teegala LR, Kondeti V, Adapala RK, Keshamouni VG, Kanaoka Y, Austen KF, Thodeti CK, Paruchuri S. Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>116<\/b>, 199\u2013204 (2019).","DOI":"10.1073\/pnas.1817325115"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wilken E, Bennji S, Symons G, Williams PG, Allwood B. Treatment of pulmonary arterial hypertension: a review of drugs available for advanced therapy. <i>Afr. J. Thorac. Crit. Care Med.<\/i>, <b>25<\/b>, 14 (2019).","DOI":"10.7196\/SARJ.2019.v25i1.236"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Storms W, Michele TM, Knorr B, Noonan G, Shapiro G, Zhang J, Shingo S, Reiss TF. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged \u22656 years. <i>Clin. Exp. Allergy<\/i>, <b>31<\/b>, 77\u201387 (2001).","DOI":"10.1046\/j.1365-2222.2001.00969.x"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/10\/49_b26-00345\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:20:53Z","timestamp":1791606053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/10\/49_b26-00345\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00345","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"article-number":"b26-00345"}}